Jean Elizze Charles, DO
Dermatology · Georgetown, TXNPI 1376075507
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $142,087 of the $154,003 with a category attached, or 92.3%. Galderma Laboratories, L.p. accounts for 93.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $84,414 and has fallen 68.0% since, to $27,011 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 412 payments — averaging $373.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$144K
- AbbVie$2K
- Johnson & Johnson$2K
- Merz North America, Inc.$1K
- Amgen$594
- Lilly USA, LLC$538
- plus $4K from 21 others
What the payments were for
- Speaking & faculty fees$142,08792%
- Travel & lodging$2,0621%
- Food & beverage$9,1866%
- Education$6680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 22 | $143,533 |
| AbbVie(2 entities) | 96 | $2,398 |
| Johnson & Johnson | 81 | $2,006 |
| Merz North America, Inc. | 5 | $1,214 |
| Amgen | 22 | $594 |
| Lilly USA, LLC | 22 | $538 |
| Regeneron Healthcare Solutions, Inc. | 24 | $422 |
| Novartis | 18 | $391 |
| Sanofi | 16 | $386 |
| Sun Pharmaceutical Industries Inc. | 14 | $327 |
| Arcutis Biotherapeutics, Inc. | 8 | $327 |
| Incyte Corporation | 10 | $290 |
| UCB, Inc. | 11 | $283 |
| E.r. Squibb & Sons, L.L.C. | 11 | $226 |
| Pfizer | 12 | $208 |
| LEO Pharma Inc. | 10 | $182 |
| Dermavant Sciences, Inc. | 11 | $168 |
| Revance Therapeutics, Inc. | 2 | $120 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $111 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $84 |
| Fresenius Kabi USA, LLC | 2 | $46 |
| Novocure Inc. | 1 | $38 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $25 |
| Biofrontera Inc. | 1 | $23 |
| Almirall LLC | 1 | $19 |
| LNHC, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$154,003 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 31 | $1,463 |
| Ketoconazole | 54 | $676 |
| Betamethasone Dipropionate | 11 | $568 |
| Metronidazole | 11 | $505 |
| Triamcinolone Acetonide | 60 | $500 |
| Doxycycline Hyclate | 32 | $456 |
| Hydrocortisone | 20 | $87 |
| Minoxidil | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Georgetown
- Alok VijGeorgetown$192K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- Daniel CarrascoAustin$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.